Immutep Limited

IMMP ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2025 Jun 2024 Jun 2023 Jun 2022 Jun 2021 Jun 2020 Jun 2019 Jun 2018
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense
Operating Income
Operating Margin
Interest Expense
Pretax Income
Income Tax Expense
Net Income
Net Margin
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Basic) 1.46B 1.45B 1.19B 866.2M 748.2M 487.6M 3.39B 3.03B
Shares Outstanding (Diluted) 1.46B 1.45B 1.19B 866.2M 748.2M 487.6M 3.39B 3.03B
Dividends Per Share